Anxiety and risk of ventricular arrhythmias or mortality in patients with an implantable cardioverter defibrillator

Psychosomatic Medicine

Volumn 75, Issue 1, 2013, Pages 36-41

  Habibović, Mirela ^a   Pedersen, Susanne S ^a,b   Van Den Broek, Krista C ^a   Theuns, Dominic A M J ^b   Jordaens, Luc ^b   Van Der Voort, Pepijn H ^c   Alings, Marco ^d   Denollet, Johan ^a  

^a TILBURG UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d AMPHIA HOSPITAL   (Netherlands)

Author keywords

anxiety; arrhythmias; implantable cardioverter defibrillator; mortality

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANXIETY DISORDER; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QRS COMPLEX; SYSTOLIC DYSFUNCTION;

EID: 84872290796     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3182769426     Document Type: Article

References (35)

1. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 2003;138:445-52.
2. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of PatientsWith Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:247-346.
3. Anderson KP. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J Interv Card Electrophysiol 2005;14:71-8.
4. Passman R, Subacius H, Ruo B, Schaechter A, Howard A, Sears SF, Kadish A. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch Intern Med 2007;167:2226-32.
5. Daubert JP, ZarebaW, Cannom DS, McNitt S, Rosero SZ,Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-65.
6. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.
7. Dunbar SB, Kimble LP, Jenkins LS, Hawthorne M, Dudley W, Slemmons M, Langberg JJ. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety 1999;9:163-8.
8. Pedersen SS, van den Broek KC, Erdman RA, Jordaens L, Theuns DA. Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace 2010;12:1446-52.
9. Whang W, Albert CM, Sears SF, Jr, Lampert R, Conti JB, Wang PJ, Singh JP, Ruskin JN, Muller JE, Mittleman MA. Depression as a predictor for appropriate shocks among patients with implantable cardioverterdefibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol 2005;45:1090-5.
10. Magyar-Russell G, Thombs BD, Cai JX, Baveja T, Kuhl EA, Singh PP, Montenegro Braga Barroso M, Arthurs E, Roseman M, Amin N, Marine JE, Ziegelstein RC. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J Psychosom Res 2011;71:223-31.
11. Burg MM, Lampert R, Joska T, Batsford W, Jain D. Psychological traits and emotion-triggering of ICD shockYterminated arrhythmias. Psychosom Med 2004;66:898-902.
12. Fries R, Konig J, Schafers HJ, Bohm M. Triggering effect of physical and mental stress on spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. Clin Cardiol 2002;25:474-8.
13. van den Broek KC, Nyklicek I, van der Voort PH, Alings M, Meijer A, Denollet J. Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients. J Am Coll Cardiol 2009;54:531-7.
14. van den Broek KC, Tekle FB, Habibovic M, Alings M, van der Voort PH, Denollet J. Emotional distress, positive affect, and mortality in patients with an implantable cardioverter defibrillator. Int J Cardiol. Published ahead of print September 29, 2011.
15. Van der Ploeg HM, Defares PB, Spielberger CD. Handleiding bij de Zelf-Beoordelings Vragenlijst (ZBV). Een nederlandstalige bewerking van de Spielberger State-Trait Anxiety Inventory. Manual for the ZBV. A Dutch-Language Adaptation of the Spielberger State-Trait Anxiety Inventory. Lisse, the Netherlands: Swets & Zeitlinger BV; 1980.
16. Kamphuis HCM, de Leeuw JRJ, Derksen R, Hauer RNW, Winnubst JAM. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock deliveryVa prospective study. Europace 2003;5:381-9.
17. Habibovic M, Van Den Broek KC, Alings M, Van der Voort PH, Denollet J. Posttraumatic stress 18 months following cardioverter defibrillator implantation: shocks, anxiety, and personality. Health Psychol 2011;31:186-93.
18. Tabachnick BG, Fidell LS, editors. Using Multivariate Statistics. 3rd ed. New York: HarperCollins; 1996.
19. Lampert R, Joska T, Burg MM, Batsford WP, McPherson CA, Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circulation 2002;106:1800-5.
20. Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. JAm Coll Cardiol 2010;56:38-46.
21. Roest AM, Martens EJ, Denollet J, de Jonge P. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med 2010;72:563-9.
22. Pereira VH, Cerqueira JJ, Palha JA, Sousa N. Stressed brain, diseased heart: a review on the pathophysiologic mechanisms of neurocardiology. Int J Cardiol. Published ahead of print April 20, 2012.
23. Lombardi F, Porta A, Marzegalli M, Favale S, Santini M, Vincenti A, De Rosa A. Heart rate variability patterns before ventricular tachycardia onset in patients with an implantable cardioverter defibrillator. Participating Investigators of ICD-HRV Italian Study Group. Am J Cardiol 2000;86: 959-63.
24. Dishman RK, Nakamura Y, Garcia ME, Thompson RW, Dunn AL, Blair SN. Heart rate variability, trait anxiety, and perceived stress among physically fit men and women. Int J Psychophysiol 2000;37:121-33.
25. Francis JL, Weinstein AA, Krantz DS, Haigney MC, Stein PK, Stone PH, Gottdiener JS, Kop WJ. Association between symptoms of depression and anxiety with heart rate variability in patients with implantable cardioverter defibrillators. Psychosom Med 2009;71:821-7.
26. Piccirillo G, Cacciafesta M, Lionetti M, Nocco M, Di Giuseppe V, Moise A, Naso C, Marigliano V. Influence of age, the autonomic nervous system and anxiety on QT-interval variability. Clin Sci (Lond) 2001;101:429-38.
27. Ziegelstein RC, Howard B. Depression and poor adherence to lipidlowering medications among patients with coronary artery disease. J Psychosom Res 2010;69:175-7.
28. Pedersen SS, Kupper N, Domburg RT. Heart and mind: are we closer to disentangling the relationship between emotions and poor prognosis in heart disease? Eur Heart J 2011;32:2341-3.
29. Chevalier P, Cottraux J, Mollard E, NanYao S, Brun S, Burri H, Restier L, Adeleine P. Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial. Am Heart J 2006;151:191.
30. Dougherty CM, Pyper GP, Frasz HA. Description of a nursing intervention program after an implantable cardioverter defibrillator. Heart Lung 2004;33:183-90.
31. Fitchet A, Doherty PJ, Bundy C, Bell W, Fitzpatrick AP, Garratt CJ. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial. Heart 2003;89: 155-60.
32. Salmoirago-Blotcher E, Ockene IS. Methodological limitations of psychosocial interventions in patients with an implantable cardioverter- defibrillator (ICD): a systematic review. BMC Cardiovasc Disord 2009;9:9.
33. Pedersen SS, van den Broek KC, Sears SF Jr. Psychological intervention following implantation of an implantable defibrillator: a review and future recommendations. Pacing Clin Electrophysiol 2007;30:1546-54.
34. Crossmann A, Schulz SM, Kuhlkamp V, Ritter O, Neuser H, Schumacher B, BauerW, Pauli P. A randomized controlled trial of secondary prevention of anxiety and distress in a German sample of patients with an implantable cardioverter defibrillator. Psychosom Med 2010;72:434-41.
35. Dunbar SB, Langberg JJ, Reilly CM, Viswanathan B, McCarty F, Culler SD, O'Brien MC, Weintraub WS. Effects of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol 2009;32:12.